Catching Up to Coronavirus: Emerging COVID-19 Therapies
March 12, 2021
This continuing education activity will provide a detailed overview of the management of patients with COVID-19 infections. Included in this presentation will be pathophysiology, risk factors, epidemiology, and pharmacologic management. After participating in this activity, pharmacists should have a better understanding of the disease stat and how to manage this patient population, and be a resource for other health care providers.
Target Audience
- Pharmacists
Learning Objectives
- Review the pathophysiology and clinical manifestations of COVID-19
- Evaluate current literature surrounding COVID-19 specific therapies in hospitalized patients
- Identify appropriate patients for COVID-19 specific therapies
- Develop and appropriate treatment plan based on a patient case
Additional Information
Attachment | Size |
---|---|
![]() | 157.72 KB |
![]() | 127.3 KB |
University of Rochester Medical Center
Rochester, NY
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Jeff Huntress, PharmD
Director of Pharmacy
University of Rochester Medical Center
Michelle Opipari, PharmD, BCPS
Residency Program Coordinator
University of Rochester Medical Center
Course reviewer
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient, Inc.
Presenter
Kelly Golden, PharmD
PGY-1 Pharmacy Resident
University of Rochester Medical Center

Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-098-L01-P
Available Credit
- 1.00 ACPE Pharmacist